Cyclic di AMP phosphodiesterase nanovaccine elicits protective immunity against Burkholderia cenocepacia infection in mice
Abstract Burkholderia cenocepacia causes life-threatening infections in immunocompromised patients. Treatment is challenging due to intrinsic antibiotic multiresistance, so vaccination provides an alternative approach. We aimed to identify vaccine candidates using reverse vaccinology and evaluate th...
Saved in:
Main Authors: | Wesam E. Gawad, Yosra I. Nagy, Tamer M. Samir, Ahmed Mohamed Ibrahim Mansour, Omneya M. Helmy |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-02-01
|
Series: | npj Vaccines |
Online Access: | https://doi.org/10.1038/s41541-025-01074-4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PEG-PLGA nanoparticles deposited in Pseudomonas aeruginosa and Burkholderia cenocepacia
by: Tinatini Tchatchiashvili, et al.
Published: (2024-12-01) -
Insights into the diverse roles of the terminal oxidases in Burkholderia cenocepacia H111
by: Sarah Paszti, et al.
Published: (2025-01-01) -
Editorial: Cyclic nucleotide phosphodiesterases (PDEs) signaling in the endocrine system
by: Federica Campolo, et al.
Published: (2025-01-01) -
Recent advances of nanovaccines on cancer theranostics
by: Xiaobing Yuan, et al.
Published: (2025-02-01) -
LBP-CD155 Liposome Nanovaccine Efficiently Resist Colorectal Cancer and Enhance ICB Therapy
by: Yan Y, et al.
Published: (2025-01-01)